Regulation of movement energetic costs is impaired in pre-symptomatic Huntington's disease (pHD) and in the early stages Parkinson's disease (PD)

被引：0
|
作者：
Crupi, D.
Moisello, C.
Di Rocco, A.
Perfetti, B.
Feigin, A.
Eidelberg, D.
Ghilardi, M. F.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [31] Impaired hypocretin neurotransmission in Huntington's and Parkinson's disease
    Fronczek, R.
    Overeem, S.
    Hegeman, I.
    Roelandse, F.
    Van Pelt, J.
    Maat-Schieman, M.
    Van Duinen, S.
    Roos, R.
    Lammers, G.
    SLEEP, 2006, 29 : A299 - A299
  • [32] Rasagiline provides symptomatic benefit in early Parkinson's disease (PD)
    Jankovic, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S127 - S128
  • [33] A three-year follow-up study in pre-symptomatic Huntington's disease (pHD): Trajectory control and motor learning.
    Ghilardi, M. Felice
    Feigin, Andrew
    Battaglia, Fortunato
    DiRocco, Alessandro
    Eidelberg, David
    NEUROLOGY, 2007, 68 (12) : A229 - A229
  • [34] SET-SHIFTING DEFICITS IN THE PRE-SYMPTOMATIC BACHD TRANSGENIC RAT MODEL OF HUNTINGTON'S DISEASE
    Sosti, M. V.
    Martinez-Horta, S.
    Perez Perez, J.
    Arenas, F.
    Kulisevsky, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A27 - A27
  • [35] Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study
    Reading, SAJ
    Yassa, MA
    Bakker, A
    Dziorny, AC
    Gourley, LM
    Yallapragada, V
    Rosenblatt, A
    Margolis, RL
    Aylward, EH
    Brandt, J
    Mori, S
    van Zijl, P
    Bassett, SS
    Ross, CA
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2005, 140 (01) : 55 - 62
  • [36] Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques
    Rizk-Jackson, Angela
    Stoffers, Diederick
    Sheldon, Sarah
    Kuperman, Josh
    Dale, Anders
    Goldstein, Jody
    Corey-Bloom, Jody
    Poldrack, Russell A.
    Aron, Adam R.
    NEUROIMAGE, 2011, 56 (02) : 788 - 796
  • [37] Biomarkers for the experimental therapeutics of Huntington's disease (HD) and Parkinson's disease (PD)
    Shoulson, I
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 47 - 49
  • [38] Frontal neuropsychiatric syndromes in Huntington's disease (HD) and Parkinson's disease (PD).
    Hulvershorn, LA
    Stout, JC
    Paulsen, JS
    Siemers, E
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 133 - 133
  • [39] Disorders of movement scaling during gait in Parkinson's disease and Huntington's disease
    Morris, AE
    Iansek, R
    Bilney, B
    McGinley, J
    Georgiou-Karistianis, N
    Huxhamn, F
    MOVEMENT DISORDERS, 2006, 21 : S88 - S89
  • [40] Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal doparnine in a pre-symptomatic stage model of Parkinson's disease
    Ogura, T
    Ogata, M
    Akita, H
    Jitsuki, S
    Akiba, L
    Noda, K
    Hoka, S
    Saji, M
    NEUROSCIENCE RESEARCH, 2005, 51 (03) : 299 - 308
12345